Breathe Well Live Well
|
For Severe Asthma, Most Surveyed U.S. Payers Would Reimburse a Novel …
PR Newswire (press release) Surveyed U.S. and European pulmonologists agree that reduction in rate of exacerbations is the attribute that most influences prescribing decisions in moderate to severe asthma. Clinical data and the opinions of interviewed thought leaders indicate … |
View full post on asthma – Google News
|
For Severe Asthma, Most Surveyed U.S. Payers Would Reimburse a Novel …
MarketWatch Efficacy versus price: Results of a conjoint analysis indicate that in severe asthma, U.S. pulmonologists are willing to prescribe a novel therapy with strong efficacy in reductions in exacerbations and oral corticosteroid dose even if that drug … |
View full post on asthma – Google News
|
Surveyed Pulmonologists and Payers Anticipate More Controls on Branded …
The Providence Journal BURLINGTON, Mass., March 5, 2014 /PRNewswire/ — Decision Resources Group finds that as the Affordable Care Act drives up the demand for asthma drugs, exchange-based plans will impose more cost controls and prescribing barriers than commercial … |
View full post on asthma – Google News
|
Surveyed Pulmonologists and Payers Anticipate More Controls on Branded …
PR Newswire (press release) BURLINGTON, Mass., March 5, 2014 /PRNewswire/ — Decision Resources Group finds that as the Affordable Care Act drives up the demand for asthma drugs, exchange-based plans will impose more cost controls and prescribing barriers than commercial … |
View full post on asthma – Google News
|
For Persistent Asthma, Surveyed Pulmonologists Indicate That a Reduced Rate …
PR Newswire (press release) The DecisionBase report entitled Asthma: Where do Pulmonologists and Payers Signal the Greatest Need—and Greatest Opportunity for Differentiation—for Novel Therapies for Persistent Disease? finds that surveyed U.S. and European pulmonologists and … |
View full post on asthma – Google News
|
A Higher Percentage of Surveyed Physicians Than Surveyed MCO Pharmacy …
Business Wire (press release) The lower percentage of surveyed MCO pharmacy directors selecting Advair/Seretide/Adoair may reflect payers' lower level of familiarity with asthma … |
View full post on asthma – Google News
|
For the Treatment of Asthma, Surveyed Safety-Minded Physicians May Be the Most …
MarketWatch (press release) According to the new report, Brand Perception Series: Physician Segmentation in Asthma, physicians report the greatest need in asthma treatment is for a … |
View full post on asthma – Google News